Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Biotech Race for $1B in Government Money Begins Monday
BNET Pharma
Friday, June 18, 2010 - 11:28am
tags:
funding, biotech, grants
Amylin, Alkermes gain ground on Roche drug delay
Yahoo/AP
Friday, June 18, 2010 - 11:28am
tags:
Roche, Amylin, Alkermes, diabetes, taspoglutide
Managed Care Has More Faith in the Big Pharma Model Than Big Pharma Does
InVivo
Friday, June 18, 2010 - 9:31am
tags:
managed care, Big Pharma, Quintiles
Sanofi Drops Most in Month on Concern Diabetes Drug May Raise Cancer Risk
Bloomberg
Friday, June 18, 2010 - 9:28am
tags:
Lantus, diabetes, Sanofi
FDA Warns Drug Makers On Misleading Promotional Efforts
NASDAQ.com
Friday, June 18, 2010 - 8:17am
tags:
FDA, warnings, Cumberland, Auxilium, Dainippon Sumitomo, Eisai
Medicare mulls new restrictions on anemia meds
Fierce Pharma
Friday, June 18, 2010 - 7:52am
tags:
Medicare, anemia, JNJ, Epogen, Procrit, Amgen, Aranesp
Roche Expects Delay to Taspoglutide on Safety Concern
Bloomberg
Friday, June 18, 2010 - 7:40am
tags:
Roche, taspoglutide, diabetes
FDA approves Sanofi-Aventis prostate cancer drug
Yahoo/AP
Friday, June 18, 2010 - 7:39am
tags:
FDA, prostate cancer, Sanofi, Jevtana
Mylan says FDA clears generic version of Atarax
Yahoo/AP
Friday, June 18, 2010 - 7:38am
tags:
Atarax, generics, FDA, Mylan, Teva Pharmaceuticals, anxiety
Orexigen says FDA sets Jan. 31 date for Contrave
Yahoo/AP
Thursday, June 17, 2010 - 11:03pm
tags:
FDA, Contrave, Orexigen, obesity
Adolor says pain drugs failed in midstage trial
Yahoo/AP
Thursday, June 17, 2010 - 11:02pm
tags:
Adlor, clinical trials, painkillers
Sanofi Keeps July 4 Traditions Alive With Layoff Rumors and Promises of Cuts to Come
BNET Pharma
Thursday, June 17, 2010 - 6:56pm
tags:
layoffs, cafepharma, Sanofi
Bayer Agrees to Develop Cancer Medicines With OncoMed
Bloomberg
Thursday, June 17, 2010 - 6:55pm
tags:
OncoMed, partnerships, Bayer, cancer
Merck Needs to Get Busy
Motley Fool
Thursday, June 17, 2010 - 6:51pm
tags:
Merck, FDA, Gardasil
GlaxoSmithKline lupus drug candidate does well in phase III trials
Bizjournals.com
Thursday, June 17, 2010 - 6:50pm
tags:
GSK, lupus, Benlysta, Human Genome Sciences
Should Gilead Sciences Declare a Dividend?
Seeking Alpha
Thursday, June 17, 2010 - 6:48pm
tags:
Gilead Sciences, dividends, Bristol-Myers Squibb, GSK
Andromeda receives $17.5M investments
BusinessWeek
Thursday, June 17, 2010 - 11:43am
tags:
Andromeda, Teva Pharmaceuticals, DiaPep277, type 1 diabetes
Elan Faces Double Threat To Blockbuster Drug Tysabri
WSJ
Thursday, June 17, 2010 - 11:32am
tags:
Elan, MS, Tysabri, Biogen Idec, Novartis, Gilenia
Arginetix, Immune Control Inc. merge to form Corridor Pharmaceuticals Read more: Arginetix, Immune Control Inc. merge to form Corridor Pharmaceuticals - Baltimore Business Journal
bizjournals.com
Thursday, June 17, 2010 - 11:29am
tags:
Arginetix, Immune Control Inc, Corridor Pharmaceuticals
Innophos Holdings, Inc. Declares Quarterly Dividend
American Chronicle
Thursday, June 17, 2010 - 11:27am
tags:
Innophos

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.